Diabetic Nephropathy: Pathogenesis to Cure

被引:16
作者
Kushwaha, Kriti [1 ]
Kabra, Uma [2 ]
Dubey, Rupal [1 ,3 ]
Gupta, Jeena [1 ,4 ]
机构
[1] Lovely Profess Univ, Sch Bioengn & Biosci, Dept Biochem, Phagwara 144411, Punjab, India
[2] Parul Univ, Parul Inst Pharm, Dept Pharmaceut Chem, Vadodara 391760, Gujarat, India
[3] Lovely Profess Univ LPU, Sch Pharmaceut Sci, Dept Med Lab Sci, Jalandhar Delhi GT Rd, Phagwara 144411, Punjab, India
[4] Lovely Profess Univ LPU, Sch Bioengn & Biosci, Dept Biochem, Jalandhar Delhi GT Rd, Phagwara 144411, Punjab, India
关键词
Diabetic nephropathy; urinary albumin excretion; microalbuminuria; macroalbuminuria; renal damage; pathogenesis; GLYCATION END-PRODUCTS; NECROSIS-FACTOR-ALPHA; BLOOD-PRESSURE; RENAL HYPERTROPHY; JAPANESE PATIENTS; SODIUM RETENTION; THERAPY PREVENTS; KIDNEY INJURY; TNF-ALPHA; INFLAMMASOME;
D O I
10.2174/1389450123666220820110801
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
Diabetic nephropathy (DN) is a leading cause of end-stage renal disorder (ESRD). It is defined as the increase in urinary albumin excretion (UAE) when no other renal disease is present. DN is categorized into microalbuminuria and macroalbuminuria. Factors like high blood pressure, high blood sugar levels, genetics, oxidative stress, hemodynamic and metabolic changes affect DN. Hyperglycemia causes renal damage through activating protein kinase C (PKC), producing advanced end glycation products (AGEs) and reactive oxygen species (ROS). Growth factors, chemokines, cell adhesion molecules, inflammatory cytokines are found to be elevated in the renal tissues of the diabetic patient. Many different and new diagnostic methods and treatment options are available due to the increase in research efforts and progression in medical science. However, until now, no permanent cure is available. This article aims to explore the mechanism, diagnosis, and therapeutic strategies in current use for increasing the understanding of DN.
引用
收藏
页码:1418 / 1429
页数:12
相关论文
共 119 条
  • [11] Randomized trial of an inhibitor of formation of advanced glycation end products in diabetic nephropathy
    Bolton, WK
    Cattran, DC
    Williams, ME
    Adler, SG
    Appel, GB
    Cartwright, K
    Foiles, PG
    Freedman, BI
    Raskin, P
    Ratner, RE
    Spinowitz, BS
    Whittier, FC
    Wuerth, JP
    [J]. AMERICAN JOURNAL OF NEPHROLOGY, 2004, 24 (01) : 32 - 40
  • [12] Global Economic Burden of Diabetes in Adults: Projections From 2015 to 2030
    Bommer, Christian
    Sagalova, Vera
    Heesemann, Esther
    Manne-Goehler, Jennifer
    Atun, Rifat
    Baernighausen, Till
    Davies, Justine
    Vollmer, Sebastian
    [J]. DIABETES CARE, 2018, 41 (05) : 963 - 970
  • [13] Anemia with erythropoietin deficiency occurs early in diabetic nephropathy
    Bosman, DR
    Winkler, AS
    Marsden, JT
    Macdougall, IC
    Watkins, PJ
    [J]. DIABETES CARE, 2001, 24 (03) : 495 - 499
  • [14] Genetics of diabetes complications.
    Bowden D.W.
    [J]. Current Diabetes Reports, 2002, 2 (2) : 191 - 200
  • [15] Effect of high-dose mineralocorticoid receptor antagonist eplerenone on urinary albumin excretion in patients with type 2 diabetes and high cardiovascular risk: Data from the MIRAD trial
    Brandt-Jacobsen, Niels H.
    Johansen, Marie Louise
    Rasmussen, Jon
    Forman, Julie L.
    Holm, Maria Refsgaard
    Faber, Jens
    Rossignol, Patrick
    Schou, Morten
    Kistorp, Caroline
    [J]. DIABETES & METABOLISM, 2021, 47 (04)
  • [16] Low glomerular filtration rate in normoalbuminuric type 1 dihibetic patients - An indicator of more advanced glomerular lesions
    Caramori, ML
    Fioretto, P
    Mauer, M
    [J]. DIABETES, 2003, 52 (04) : 1036 - 1040
  • [17] Carrara F., 2018, J Lab Precis Med, V3, P77, DOI DOI 10.21037/JLPM.2018.09.07
  • [18] Ceol M, 2000, J AM SOC NEPHROL, V11, P2324, DOI 10.1681/ASN.V11122324
  • [19] The Lancet Commission on diabetes: using data to transform diabetes care and patient lives
    Chan, Juliana C. N.
    Lim, Lee-Ling
    Wareham, Nicholas J.
    Shaw, Jonathan E.
    Orchard, Trevor J.
    Zhang, Ping
    Lau, Eric S. H.
    Eliasson, Bjorn
    Kong, Alice P. S.
    Ezzati, Majid
    Aguilar-Salinas, Carlos A.
    McGill, Margaret
    Levitt, Naomi S.
    Ning, Guang
    So, Wing-Yee
    Adams, Jean
    Bracco, Paula
    Forouhi, Nita G.
    Gregory, Gabriel A.
    Guo, Jingchuan
    Hua, Xinyang
    Klatman, Emma L.
    Magliano, Dianna J.
    Ng, Boon-Peng
    Ogilvie, David
    Panter, Jenna
    Pavkov, Meda
    Shao, Hui
    Unwin, Nigel
    White, Martin
    Wou, Constance
    Ma, Ronald C. W.
    Schmidt, Maria I.
    Ramachandran, Ambady
    Seino, Yutaka
    Bennett, Peter H.
    Oldenburg, Brian
    Gagliardino, Juan Jose
    Luk, Andrea O. Y.
    Clarke, Philip M.
    Ogle, Graham D.
    Davies, Melanie J.
    Holman, Rury R.
    Gregg, Edward W.
    [J]. LANCET, 2020, 396 (10267) : 2019 - 2082
  • [20] Chen XH, 2022, FOOD FUNCT, V13, P3258, DOI [10.1039/d1fo03615g, 10.1039/D1FO03615G]